These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6463720)

  • 1. [Analysis of the clinical forms of hepatitis B in light of the viral-immunogenetic concept of its pathogenesis].
    Sorinson SN; Korochkina OV; Iakhontov NE
    Sov Med; 1984; (5):27-30. PubMed ID: 6463720
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of severe forms of serum hepatitis type B].
    Ketiladze ES; Farber NA; Zhilina NN; Vorozhbieva TE; Savitskiĭ GI
    Klin Med (Mosk); 1980 Jan; 58(1):46-52. PubMed ID: 6966013
    [No Abstract]   [Full Text] [Related]  

  • 3. Fulminant B viral hepatitis: role of delta agent.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differences in the mechanism of development of HBsAg-positive and HBsAg-negative forms of chronic active hepatitis].
    Dzhalalova VA; Drozd TN; Beketova TP; Skriabina EG
    Klin Med (Mosk); 1986 Nov; 64(11):73-8. PubMed ID: 3821039
    [No Abstract]   [Full Text] [Related]  

  • 5. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoantibodies to intermediate filaments in acute viral hepatitis.
    Chandra M; Golani DD; Sachdeva S; Bihari N; Sharma DK
    Indian J Med Res; 1986 Sep; 84():247-51. PubMed ID: 3817924
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors of nonspecific resistance in hepatitis B and acute hepatic insufficiency].
    Rakhmanova AG; Muradnazarova TB; Amerikantseva NF; Demidenko TP; Badosova NV
    Sov Med; 1990; (10):22-5. PubMed ID: 2293383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibronectin in acute and chronic hepatitis].
    Malaia LT; Babak OIa; Iabluchanskiĭ NI; Sharov EI
    Klin Med (Mosk); 1990 Nov; 68(11):37-9. PubMed ID: 2283810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic elements in chronic HBV hepatitis in childhood].
    Giacchino R; Ciravegna B; Navone C; Facco F; Ferrea G; Canepa M
    Minerva Pediatr; 1988 Jul; 40(7):395-400. PubMed ID: 3205219
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of the appearance and dynamics of immune complexes in patients with chronic hepatitis].
    Bozić M; Milosević-Jovcić N; Cvorić M; Nikolić V; Tosić Lj
    Srp Arh Celok Lek; 1983 Jul; 111(7):889-903. PubMed ID: 6675191
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic aspects of acute viral hepatitis at different ages].
    Botsvadze ESh; Katsitadze TK; Kvitashvili AA; Vashakidze ET
    Ter Arkh; 1986; 58(2):55-9. PubMed ID: 3704939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of heredity in the development of chronic viral hepatitis].
    Zhurkin AT
    Vestn Akad Med Nauk SSSR; 1988; (12):46-9. PubMed ID: 2977032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic significance and clinical course of chronic delta-positive hepatitis in children (comparison with chronic delta-negative hepatitis in childhood and delta-positive forms in adults)].
    Calzia R; Navone C; Ciravegna B; Bonura ML; Giovale M; Massacane R; Piscopo R; Santoni O; Zauli C
    G Clin Med; 1984; 65(5-6):255-60. PubMed ID: 6468807
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum immunoglobulin levels during acute viral B hepatitis.
    Markus R; Baumgarten R; Fengler JD
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(5):219-22. PubMed ID: 6641595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of severe forms of viral hepatitis with injections of human leukocytic interferon].
    Kvitashvili MA; Kuznetsov VP; Pokrovskiĭ VI
    Ter Arkh; 1982; 54(9):28-32. PubMed ID: 6983735
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunocorrective therapy of severe forms of hepatitis B].
    Arkhipov GS; Shabalin VV; Makarova TA; Trug AD; Khriapov BT
    Ter Arkh; 1985; 57(10):94-7. PubMed ID: 3878605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of clinical type of hepatitis B to human leukocyte. A preliminary study.
    Fan ZP; Cai HF
    Chin Med J (Engl); 1985 Mar; 98(3):187-90. PubMed ID: 3924511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoglobulins in viral hepatitis].
    Il'inskiĭ IuA; Skvortsov VM; Dvurechenskaia GS; Luchshev VI; Nikiforov ND
    Sov Med; 1981; (9):41-3. PubMed ID: 7313793
    [No Abstract]   [Full Text] [Related]  

  • 19. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A; Barna K; Bajtai G; Hollós I; Ambrus M; Kovács M; Jávor T
    Acta Med Acad Sci Hung; 1980; 37(3):269-81. PubMed ID: 7457030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.